Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway

Cell Death and Differentiation

Volumn 6, Issue 1, 1999, Pages 22-27

  Grilli, Mariagrazia ^b   Memo, Maurizio ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Schering Plough Research Institute   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cerebellar neurons; Cyclin dependent kinase; Excito toxicity; Glutamate; Neurodegenerative diseases; Tumour suppressor gene

Indexed keywords

EXCITOTOXIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERMEDIN; PROTEIN P21; PROTEIN P53;

APOPTOSIS; CELL CYCLE; CELL DEATH; HUMAN; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032944799     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400463     Document Type: Review

References (77)

1. Heintz N (1993) Cell death and the cell cycle: a relationship between transformation and neurodegeneration ? TiBS. 18: 449-451
2. Choi DW (1988) Glutamate neurotoxicity and diseases of the neurons system. Neuron. 1: 623-634
3. Lipton SA and Rosemberg PA (1994) Excitatory aminoacids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330(9): 613-622
4. Robbins JH, Otsuka F, Tarone RE, Polinsky RJ, Brumback RA and Nee LE (1985) Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines. J. Neurol. Neurosurg. Psychiatry 48: 916-923
5. Duguid JR, Bohmot CW, Liu N and Tourtellotte WW (1989) Changes in braingene expression shared by scrapie and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86: 7260-7264
6. Mazzarello P, Poloni M, Spadari S and Focher F (1992) DNA repair mechanism in neurological diseases: facts and hypotheses. J. Neurological Sci. 112: 4-14
7. Boerrigter METI, Wei JY and Vijg J (1992) DNA repair and Alzheimer's disease. J. Gerontol. 47: B177-B184
8. Portera-Cailliau C, Hedreen JC, Price DL and Koliatsos VE (1995) Evidence of apoptotic cell death in Huntington disease and excitotoxic animal model. J. Neurosci. 15: 3775-3787
9. Liu PK, Hsu CY, Dizdaroglu M, Floyd RA, Kow YW, Karakaya A, Rabow LE and Cui J-K (1996) Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J. Neurosci. 16: 6795-6806
10. Sen R and Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716
11. Grilli M, Chiu JJS and Lenardo MJ (1993) NF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System. Intern. Rev. Citol. 143: 1-62
12. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-681
13. O'Neill LAJ and Kaltschmidt C (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. TINS. 20: 252-258
14. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H and Baeuerle PA (1994a) Constitutive NF-κB activity in neurons. Mol. Cell Biol. 14: 3981-3992
15. Kaltschmidt C, Kaltschmidt B and Baeuerle PA (1993) Brain synapses contain inducible forms of the transcription factor NF-κB. Mech. Development 43: 135-147
16. Guerrini I, Blasi F and Denis-Donini S (1995) Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. USA. 92: 9077-9081
17. Medberg PJ, Kinney WR, Valcourt EG and Routtenberg A (1996) Gene expression of the transcription factor NF-κB in hippocampus: regulation by synaptic activity. Mol. Brain Res. 38: 179-190
18. Suzuki T, Mitake S, Okumura-Noji K, Yang JP, Fujii T and Okamoto T (1997) Presence of NF-κB-like and IκB-like immunoreactivities in postsynaptic densities. Neuroreport. 8: 2931-2935
19. Sparacio SM, Zhang Y, Vilcek J and Benveniste EN (1992) Cytokine regulation of Interleukin 6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J. Neuroimmunol. 39: 231-242
20. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg GW, Wekerle H, Baeuerle PA and Gehrmann J (1994b) Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55: 99-106
21. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bonn-Matthaei R, Baeuerle PA and Barde Y-A (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272: 542-545
22. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D and Schmidt AM (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691
23. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y and Hirsh EC (1997) Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94: 7531-7536
24. Atwood WJ, Tornatore CS, Traub R, Conant K, Drew PD and Major EO (1994) Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/ p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. AIDS Res. Hum. Retroviruses 1: 1207-1211
25. Dollard SC, James HJ, Sharer LR, Epstein LG, Gelbard HA and Dewourst S (1995) Activation of nuclear factor-kappa B in brains from children with HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 21: 518-528
26. Jung M, Zhang Y, Lee S and Dritschilo A, (1995) Correction of radiation sensitivity in ataxia teleangectasia cells by truncated IκBa. Science 268: 1619-1621
27. Clemens JA, Stephenson DT, Yin T, Smalstig ER, Panetta JA and Little S (1998) Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kB in rats. Stroke 29: 677-682
28. Yang K, Mu XS and Hayes RL (1995) Increased cortical nuclear factor-kappa B (NF-kappa B) DNA binding activity after traumatic brain injury in rats. Neurosci. Letts. 19: 101-104
29. Quin ZH, Wang Y, Nakai M and Chase T (1998) Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 53: 33-42
30. Grilli M, Goffi F, Memo M and Spano PF. (1996a) Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271: 15002-15007
31. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA and Kaltschmidt C (1997) Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94: 2642-2647
32. Kessler JA, Ludham WH, Freidin MM, Hall DH, Michaelson MD, Spray DC, Dougherty M and Batter DK (1993) Cytokine-induced programmed cell death of cultured sympathetic neurons. Neuron. 11: 1123-1132
33. Talley AK, Dewurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman BE and Gelbard HA (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crm-A. Mol. Cell. Biol. 15: 2359-2366
34. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL and Stern D (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1: 693-699
35. Whittemore ER, Loo DT and Cotman CV (1994) Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport. 5: 1485-1488
36. Tong L and Perez-Polo JR (1995) Transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation. Neurosci. Lett. 191: 137-140
37. Abbadie C, Kabrun N, Bouali F, Smardova J, Stehelin D, Vandenbender B and Enrietto PJ (1993) High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75: 899-912
38. Lin KI, Lee SH, Narayanan R, Baraban JM, Mardwick JM and Ratan RR (1995) Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131: 1149-1161
39. Grimm S, Bauer MK, Baeuerle PA and Shulze-Osthoff K (1996) Bcl-2 down-regulates the activity of transcription factor NF-kappa B induced upon apoptosis. J. Cell Biol. 134: 13-23
40. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92: 9328-9332
41. Barger SW and Mattson MP (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's κ-amyloid precursor. Brain Res. Mol. Brain Res. 40: 116-126
42. Lezoualc'h F, Sagara Y, Holsboer F and Behl C (1998) High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18: 3224-3232
43. Baichwal M and Baeuerle PA (1997) Activate NF-kappa B or die ? Curr. Biol. 7: 94-96
44. Grilli M and Memo M (1997) Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity? Molecular Psychiatry 2: 192-194
45. Grilli M and Memo M (1998) NF-κB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 56: in press
46. Lin KI, DiDonato JA, Hoffmann A, Hardwick J and Ratan RR (1998) Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibited alphavirus-induced apoptosis. J. Cell Biol. 141: 1479-1487
47. Jung M, Zhang Y, Dimtchev A and Dritschilo A (1998) Impaired regulation of Nuclear Factor-κB results in apoptosis induced by gamma radiation. Radiation Res. 149: 596-601
48. Bauer MKA, Vogt M, Los M, Siegel J, Wesselborg S and Shulze-Osthoff K (1998) Role of reactive oxigen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273: 8048-8055
49. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358: 15-16
50. Vogelstein B and Kinzier KW (1992) p53 function and dysfunction. Cell, 70: 523-526
51. Almog N and Rotter V (1997) Involvement of p53 in cell differentiation and development. Biochem. Biophys. Acta. 1333: 1-27
52. Donehover LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221
53. Armstrong JF, Kaufman MH, Harrison DJ and Clarke AR (1995) High-frequency developmental abnormalities in p53-deficient mice. Current Biology 5: 931-936
54. Chopp M, Li Y, Zhang ZG and Freytag SO (1992) p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys. Res. Commun. 182: 1201-1207
55. Li Y, Chopp M, Zhang ZG, Zaloga C, Neiwenhuis L and Gautam S (1994) p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 25: 849-855
56. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M and Schreiber SS (1994) p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA. 89: 12028-12032
57. Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA and Morrison RS (1996) Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16: 6753-6765
58. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA and Schwartzkroin PA (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16: 1337-1345
59. Hirata H and Cadet JL (1997a) p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies. J. Neurochem. 69: 780-790
60. Hirata H and Cadet JL (1997b) Methamphetamine-induced serotonin neurotoxicity is attenuated in p53-knockout mice. Brain Res. 768: 345-348
61. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y and Taniguchi T (1997) Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232: 418-421
62. de la Monte SM, Sohn YK and Wands JR (1997) Correlates of p53- and Fas(CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152: 73-83
63. Nagy Z, Esiri MM and Smith AD (1997) Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta. Neuropathol. (Berl). 93: 294-300
64. Nicotera P, Ankarcrona M, Bonfoco E, Orrenius S and Lipton SA (1997) Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72: 95-101
65. Grilli M, Pizzi M, Memo M and Spano PF (1996b) Neuroprotection by salicylate through blockade of NF-κB activation. Science 274: 1383-1385
66. Wu H and Lozano G (1994) NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269: 20067-20074
67. Uberti D, Belloni M, Grilli M, Spano PF and Memo M (1998) Induction of tumour suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurons triggered by excitatory aminoacids. Eur. J. Neurosci. 10: 245-256
68. Enokido Y, Araki T, Tanaka K and Hatanaka H (1996) Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur. J. Neurosci. 8: 1812-1821
69. El-Deiry WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potent mediator of p53 tumor suppression. Cell 75: 817-825
70. WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4: 835-838
71. Palombo F, Hughes M, Jiricny J, Truong O and Hsuan J (1994) Mismatch repair and cancer. Nature 367: 417-418
72. Belloni M, Uberti D, Rizzini C, Torsello A, Spano P.F and Memo M (1997) Kamic acid activation of the DNA mismatch repair protein MSH2 in rat brain. Soc. Neurosci. Abstr. 23: 2218
73. Didier M, Bursztajn S, Adamec E, Passani L, Nixon RA, Coyle JT, Wei JY and Berman SA (1996) DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J. Neurosci. 16: 2238-2250
74. Jayaraman JL and Prives C. (1995) Activation of p53 sequence-specific DNA binding by short single strand of DNA requires the p53 C-terminus. Cell 81: 1021-1029
75. Lee S, Elenbaas B, Levine A and Griffith J (1995) p53 and its 14 KDa C-terminus domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013-1020
76. Eizenberg O, Faber-Elman A, Gottlier E, Oren M, Rotter V and Schwartz M (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol. 16: 5178-5185
77. Kobayashi T, Ruan S, Jabbur JR, Consoli U, Clodi K, Shiku H, Owen-Schaubi B, Andreeff M, Reed JC and Zhang W (1998) Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C-treatment. Cell Death & Differ. 5: 584-591